Sign in to continue:

Tuesday, July 28th, 2026

MicroVision Proposes Reverse Stock Split to Preserve Nasdaq Listing and Enhance Shareholder Value Ahead of 2026 Annual Meeting

MicroVision Files Preliminary Proxy Statement; Proposes Reverse Stock Split to Support Nasdaq Compliance and Capital Flexibility

Key Highlights for Investors

  • MicroVision (Nasdaq: MVIS) has filed a preliminary proxy statement for its 2026 Annual Meeting of Shareholders, scheduled for July 10, 2026. The meeting will be held virtually.
  • Critical Proposal: Shareholders will vote on granting the Board of Directors the authority to implement a reverse stock split. This is designed to preserve the company’s Nasdaq listing, support capital flexibility, and achieve a targeted stock price to attract stable, value-enhancing capital.
  • Leadership Update: CEO Glen DeVos, who took the helm just eight months ago, emphasized rapid advancements in technology, product portfolio, and commercial engagement, aiming to position MicroVision for commercial success.
  • Chairman’s Statement: Chairman Robert Carlile underscored the Board’s appreciation for shareholder support and expressed confidence in management’s ability to execute the strategic plan and build long-term value.
  • Product & Market Position: MicroVision is a leading developer of next-generation lidar-based perception solutions, targeting automotive, industrial, and security & defense markets. The company boasts a broad portfolio of both short- and long-range lidar products, solid-state sensor technology, advanced architectures, and open software solutions, with engineering centers in the U.S. and Germany.

Details Investors Need to Know

  • Reverse Stock Split Proposal:

    • This proposal is significant and potentially price-sensitive. If approved, it will give the Board the right to conduct a reverse stock split at its discretion.
    • The main motivation is to maintain MVIS’s listing on Nasdaq by complying with minimum bid price requirements and to present a more attractive capital structure to institutional investors.
    • A reverse split can reduce share count but increase share price, often interpreted by the market as an attempt to avoid delisting or attract new capital, which can lead to increased volatility in the share price.
  • Operational Progress:

    • Since the CEO transition, MicroVision reports progress in technical expertise, product expansion, and commercial engagement, all aimed at accelerating the path to profitability and market relevance.
    • The company is targeting real-world performance and automotive-grade reliability, with a focus on scalability and cost efficiency.
  • Shareholder Action Required:

    • Shareholders are strongly encouraged to review the proxy materials once available and vote on the reverse split and other proposals at the Annual Meeting.
    • Definitive proxy materials will be filed with the SEC and made available via the company’s investor relations website.

Potential Price-Sensitive Information

  • The reverse stock split is a material event that could directly impact share price volatility and investor sentiment.
  • Maintaining Nasdaq listing is critical for liquidity, institutional investment, and ongoing capital raising efforts. Failure to secure approval for the reverse split could risk delisting, which historically has severe negative impacts on share value.
  • The Board and management are taking proactive steps to ensure the company’s strategic execution and capital market readiness, which are positive signals to long-term investors.

Forward-Looking Statements and Risks

  • MicroVision cautions that forward-looking statements—regarding Nasdaq compliance, market position, product launches, and capital-raising efforts—involve risks such as limited cash, the need for additional capital, market acceptance, execution by commercial partners, competitive landscape, regulatory factors, and other risks detailed in SEC filings.

Contact Information


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review all publicly available materials and consult their own advisors before making any investment decisions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ.

View MICROVISION, INC. Historical chart here



BriaCell Therapeutics Corp. (BCTX) Q3 2026 Quarterly Report: Financial Results, Nasdaq Listing, and Key Disclosures

BriaCell Therapeutics Corp. Q3 2026 Financial Report: Key Hi...

Nordicus Partners Corporation Files Form 8-K With SEC – Key Details, Address, and Executive Information

Nordicus Partners Corporation Files Form 8-K - Key Takeaways...